Jasper therapeutics, inc.JSPR.US Overview
JSPR Overall Performance
JSPR AI Analysis & Strategy
JSPR Recent Performance
-6.16%
Jasper therapeutics, inc.
0.81%
Avg of Sector
-1.14%
S&P500
JSPR PowerScanner
JSPR Key Information
JSPR Valuation Metrics
JSPR Earnings Table
JSPR Profile
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.